Oncology Drugs Market Global Briefing 2022: Ukraine-Russia War Impact
Report Highlights
Including: Lung Cancer Drugs; Pancreatic Cancer Drugs; Breast Cancer Drugs; Prostate Cancer Drugs; Ovarian Cancer Drugs; Colorectal Cancer Drugs; Gastric Cancer Drugs; Kidney Cancer Drugs; Brain Tumor Drugs; Thyroid Cancer Drugs; Skin Cancer Drugs; Bladder Cancer Drugs; Cervical Cancer Drugs; Blood Cancer Drugs; Other Oncology Drugs
Global oncology drugs market was worth $199.7 billion in 2021, it was the second largest segment within the market accounting for 13.7%. In terms of per capita consumption, the market was $26.0 and in terms of global GDP, the market was 0.23%. Oncology drugs was the second largest segment within the market accounting for 13.7% preceded and followed by anti-infective drugs at 15.1% and central nervous system drugs at 11.6% respectively.
Oncology Drugs Market Global Briefing 2022: Ukraine-Russia War Impact provides strategists, marketers and senior management with the critical information they need to assess the global oncology drugs sector.
Reasons to Purchase
- Fully updated for 2022 with Ukraine-Russia War Impact.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Description
Oncology Drugs Market Global Briefing 2022: Ukraine-Russia War Impact from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the oncology drugs market revenues, covering both the historic growth of the market and forecasting the future.
- Market segmentations break down the key sub sectors which make up the market.
- The regional breakdowns section gives the size of the market geographically.
- The trends and strategies section highlights the likely future developments in the oncology drugs market and suggests approaches.
Scope
Markets Covered: Lung Cancer Drugs; Pancreatic Cancer Drugs; Breast Cancer Drugs; Prostate Cancer Drugs; Ovarian Cancer Drugs; Colorectal Cancer Drugs; Gastric Cancer Drugs; Kidney Cancer Drugs; Brain Tumor Drugs; Thyroid Cancer Drugs; Skin Cancer Drugs; Bladder Cancer Drugs; Cervical Cancer Drugs; Blood Cancer Drugs; Other Oncology Drugs
Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa
Time series: Five years historic and forecast
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Global Oncology Drugs Market, Historic Market Size, 2016-2021, $
- Table 2 : Global Oncology Drugs Market, Forecast Market Size, 2021-2026, $
- Table 3 : Global Oncology Drugs Market, Split By Segment, 2021, $
- Table 4 : Global Oncology Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
- Table 5 : Global Oncology Drugs Market, Split By Region, 2021, $
- Table 6 : Global Oncology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026
- Table 7 : Oncology Drugs Market Data Sources
- Figure 1 : Global Oncology Drugs Market, Historic Market Size, 2016-2021, $
- Figure 2 : Global Oncology Drugs Market, Forecast Market Size, 2021-2026, $
- Figure 3 : Global Oncology Drugs Market, Split By Segment, 2021, $
- Figure 4 : Global Oncology Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
- Figure 5 : Global Oncology Drugs Market, Split By Region, 2021, $
- Figure 6 : Global Oncology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Oncology Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery
Including: Blood Cancer; Breast Cancer; Lung Cancer; Cervical Cancer; Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma); Colorectal Cancer; Prostate Cancer; Kidney Cancer; Gastric Cancer; Brain Tumor; Skin Cancer; Ovarian Cancer; Bladder Cancer; Pancreatic Cancer; Thyroid Cancer
Covering: F. Hoffmann-La Roche Ltd.; Novartis AG; Johnson & Johnson; Pfizer Inc.; AstraZeneca
...Oncology Drugs Market Global Briefing 2020: Covid 19 Impact and Recovery
Including: Blood Cancer; Cervical Cancer; Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Kidney Cancer; Gastric Cancer; Brain Tumor; Skin Cancer; Ovarian Cancer; Bladder Cancer; Pancreatic Cancer; Thyroid Cancer; Non-Small Cell Lung Cancer; Others
Oncology Drugs Market Competitor Briefing 2019
Including: Blood Cancer; Cervical Cancer; Lung Cancer; Breast Cancer; Colorectal Cancer; Prostate Cancer; Non-Small Cell Lung Cancer; Others
Covering: Celgene Corporation; Novartis AG; Bristol-Myers Squibb; F. Hoffmann-La Roche Ltd.; Pfizer
Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research
Company (TBRC). The secondary sources include the data published ...
Oncology Drugs Market Global Briefing
Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market intelligence databases and annual reports. Insights on the current market scenario, historic and forecast market drivers were gathered from industry reports and news articles.
Note on ...
Oncology Drugs Market Global Briefing 2018
Including: Oncology Drugs, Drugs For Blood Cancer, Breast Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Colorectal Cancer, Thyroid Cancer, Non-Small Cell Lung Cancer, Gastric Cancer, Brain
Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Bladder Cancer and Others.
Covering: F. Hoffmann-La Roche Ltd., Novartis AG And Gilead Sciences, Inc.
Research Methodology
The Business Research Company’s reports are based on ...
Oncology Drugs Market Global Briefing 2017
Including: Blood Cancer, Breast Cancer, Cervical Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Kidney Cancer, Gastric Cancer, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Bladder Cancer, Thyroid Cancer, Others.
Covering: F. Hoffmann-La Roche Ltd., Novartis AG, Gilead Sciences, Inc., Bayer AG, Takeda Pharmaceuticals, Johnson & Johnson, Pfizer Inc., Boehringer Ingelheim GmbH, Eli Lilly And Company, ...